[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT1256386B - Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo - Google Patents

Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo

Info

Publication number
IT1256386B
IT1256386B ITMI922603A ITMI922603A IT1256386B IT 1256386 B IT1256386 B IT 1256386B IT MI922603 A ITMI922603 A IT MI922603A IT MI922603 A ITMI922603 A IT MI922603A IT 1256386 B IT1256386 B IT 1256386B
Authority
IT
Italy
Prior art keywords
drug
oil
pharmaceutical compositions
cross
compositions including
Prior art date
Application number
ITMI922603A
Other languages
English (en)
Inventor
Luigi Boltri
Original Assignee
Luigi Boltri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luigi Boltri filed Critical Luigi Boltri
Priority to ITMI922603A priority Critical patent/IT1256386B/it
Publication of ITMI922603A0 publication Critical patent/ITMI922603A0/it
Priority to EP93118278A priority patent/EP0598337B1/en
Priority to ES93118278T priority patent/ES2132162T3/es
Priority to DE69324442T priority patent/DE69324442T2/de
Priority to AT93118278T priority patent/ATE178787T1/de
Publication of ITMI922603A1 publication Critical patent/ITMI922603A1/it
Application granted granted Critical
Publication of IT1256386B publication Critical patent/IT1256386B/it
Priority to US08/997,463 priority patent/US6107276A/en
Priority to GR990401811T priority patent/GR3030732T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Composizioni farmaceutiche contenenti un farmaco poco solubile incorporato in un polimero reticolato insolubile ma rigonfiabile in acqua, un agente tensioattivo e un olio presentano caratteristiche di dissoluzione e conseguentemente di biodisponibilità nettamente migliorate rispetto al farmaco tal quale e rispetto al farmaco supportato su detto polimero.
ITMI922603A 1992-11-13 1992-11-13 Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo IT1256386B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITMI922603A IT1256386B (it) 1992-11-13 1992-11-13 Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
EP93118278A EP0598337B1 (en) 1992-11-13 1993-11-11 Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent
ES93118278T ES2132162T3 (es) 1992-11-13 1993-11-11 Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo.
DE69324442T DE69324442T2 (de) 1992-11-13 1993-11-11 Arznei Zusammensetzungen, die ein Arzneimittel, ein quervernetztes Polymer, ein Öl, und ein grenzflächenaktives Mittel enthalten
AT93118278T ATE178787T1 (de) 1992-11-13 1993-11-11 Arznei zusammensetzungen, die ein arzneimittel, ein quervernetztes polymer, ein öl, und ein grenzflächenaktives mittel enthalten
US08/997,463 US6107276A (en) 1992-11-13 1997-12-23 Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent
GR990401811T GR3030732T3 (en) 1992-11-13 1999-07-09 Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922603A IT1256386B (it) 1992-11-13 1992-11-13 Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo

Publications (3)

Publication Number Publication Date
ITMI922603A0 ITMI922603A0 (it) 1992-11-13
ITMI922603A1 ITMI922603A1 (it) 1994-05-13
IT1256386B true IT1256386B (it) 1995-12-04

Family

ID=11364286

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922603A IT1256386B (it) 1992-11-13 1992-11-13 Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo

Country Status (7)

Country Link
US (1) US6107276A (it)
EP (1) EP0598337B1 (it)
AT (1) ATE178787T1 (it)
DE (1) DE69324442T2 (it)
ES (1) ES2132162T3 (it)
GR (1) GR3030732T3 (it)
IT (1) IT1256386B (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
HUP9603364A2 (hu) * 1996-12-06 1998-12-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Ipriflavont tartalmazó csonthiány pótlására szolgáló gyógyászati készítmény és eljárás előállítására
AR012627A1 (es) 1997-04-29 2000-11-08 Sherman Bernard Charles Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
IL145140A0 (en) * 1999-03-24 2002-06-30 Fmc Corp Improved aqueous solubility pharmaceutical formulations
NZ530701A (en) * 1999-06-04 2005-09-30 Alza Corp Implantable gel compositions comprising compressed particles including the active agent in a bioerodible gel
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
WO2003007928A1 (fr) * 2001-07-17 2003-01-30 Idemitsu Kosan Co., Ltd. Medicaments prophylactiques contre l'ascite pour la volaille
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
JP4780522B2 (ja) * 2003-11-14 2011-09-28 味の素株式会社 フェニルアラニン誘導体の固体分散体または固体分散体医薬製剤
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
KR20170123724A (ko) 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
WO2009040776A1 (en) 2007-09-27 2009-04-02 Wockhardt Research Centre Self-emulsifying pharmaceutical compositions of rhein or diacerein
SG10202010355PA (en) * 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
EA201490047A1 (ru) 2011-06-17 2014-08-29 Берг Ллк Ингаляционные фармацевтические композиции
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
DE69129918T2 (de) * 1990-03-23 1999-02-04 Yoshitomi Pharmaceutical Industries, Ltd., Osaka Ein in Wasser schwerlösliches Arzneimittel enthaltende pharmazeutische Zubereitung

Also Published As

Publication number Publication date
EP0598337A3 (en) 1995-06-14
ES2132162T3 (es) 1999-08-16
US6107276A (en) 2000-08-22
EP0598337A2 (en) 1994-05-25
ITMI922603A1 (it) 1994-05-13
ATE178787T1 (de) 1999-04-15
DE69324442D1 (de) 1999-05-20
GR3030732T3 (en) 1999-11-30
DE69324442T2 (de) 1999-08-05
ITMI922603A0 (it) 1992-11-13
EP0598337B1 (en) 1999-04-14

Similar Documents

Publication Publication Date Title
IT1256386B (it) Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
JPS5579323A (en) Base
ES2029269T5 (es) Una formulacion de liberacion lenta.
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
AR003908A1 (es) Tableta de liberacion controlada
KR880701544A (ko) 이온화 가능한 의약 제제용 용해 시스템
MX9806265A (es) TABLETA QUE CONTIENE EL ANTIBIOTICO beta-LACTAMA Y PRODUCCION DE LA MISMA.
NO962040D0 (no) Mikroinnkapslede 3-piperidinyl-substituerte 1,2-benzisoksazoler og 1,2-benzisotiazoler
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
WO2002067852A3 (en) A controlled release pharmaceutical composition
KR880009639A (ko) 서방성 매트릭스 제형
DE69414840D1 (de) Akzeptabele pharmazeutische zusammensetzung enthaltend einen alkohol und einen hydrophalischen wirkstoff
TNSN01123A1 (fr) Formes posologiques nouvelles a liberation controlee
SE0004671D0 (sv) Pharmaceutical formulation
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
MY127908A (en) Improved pharmaceutical formulations.
FI970934A0 (fi) Implantoitava valukappale vaikuttavien aineiden annostelemiseksi kasveihin
CY1108863T1 (el) Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη
EA200000154A1 (ru) Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
KR850001693A (ko) 아모술랄롤 하이드로클로라이드 지속성 제제의 제조방법
DK1227797T3 (da) Farmaceutiske faststofdispersionsformuleringer
BG104527A (en) Formulations comprising dissolved paroxetine
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128